07/03/2025 1:31 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2025 1:32 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Stueland Katherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2025 6:53 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) Stueland Katherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2025 6:53 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025 4:50 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Meister Keith A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2025 4:50 PM | Casdin Eli (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2025 4:44 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) RUCH JOSHUA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2025 4:45 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) PFENNIGER RICHARD C JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2025 4:45 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Leproust Emily M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2025 4:48 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Ryan Jason (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2025 3:14 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for WGSWW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GeneDx and its competitors with MarketBeat's FREE daily newsletter.
|
06/18/2025 3:14 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Stueland Katherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2025 6:22 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) Stueland Katherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2025 6:23 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2025 4:30 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2025 7:55 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2025 6:46 PM | Corvex Management LP (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Meister Keith A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2025 4:56 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4/A | |
05/09/2025 11:28 AM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
05/06/2025 8:45 PM | Corvex Management LP (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Meister Keith A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2025 3:48 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) PFENNIGER RICHARD C JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2025 6:44 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Stueland Katherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2025 6:46 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2025 6:02 AM | GeneDx Holdings Corp. (Filer) GeneDx Holdings Corp. (Filer) GeneDx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2025 6:04 AM | GeneDx Holdings Corp. (Filer) GeneDx Holdings Corp. (Filer) GeneDx (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2025 8:51 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) Stueland Katherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2025 8:52 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2025 6:01 AM | GeneDx Holdings Corp. (Filer) GeneDx Holdings Corp. (Filer) GeneDx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/14/2025 7:00 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2025 3:11 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Stueland Katherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2025 3:12 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2025 4:10 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) Stueland Katherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2025 4:36 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2025 5:34 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) Stueland Katherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2025 5:36 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025 8:50 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 8:51 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Stueland Katherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 5:44 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) Stueland Katherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025 5:46 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2025 6:03 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) Stueland Katherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2025 6:04 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
03/11/2025 4:42 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 4:40 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Stueland Katherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 6:43 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) Stueland Katherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025 6:44 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025 5:59 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025 7:00 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2025 3:30 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Filed by)
| Form SCHEDULE 13D/A | |
02/20/2025 7:12 AM | GeneDx Holdings Corp. (Filer) GeneDx Holdings Corp. (Filer) GeneDx (Filer)
| Form S-8 POS | |
02/20/2025 7:12 AM | GeneDx Holdings Corp. (Filer) GeneDx Holdings Corp. (Filer) GeneDx (Filer)
| Form S-8 POS | |
02/20/2025 6:59 AM | GeneDx Holdings Corp. (Filer) GeneDx Holdings Corp. (Filer) GeneDx (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/20/2025 7:09 AM | GeneDx Holdings Corp. (Filer) GeneDx Holdings Corp. (Filer) GeneDx (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/20/2025 7:11 AM | GeneDx Holdings Corp. (Filer) GeneDx Holdings Corp. (Filer) GeneDx (Filer)
| Form S-8 POS | |
02/18/2025 7:01 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Filed by)
| Form SCHEDULE 13D/A | |
02/18/2025 5:50 AM | GeneDx Holdings Corp. (Filer) GeneDx Holdings Corp. (Filer) GeneDx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2025 3:26 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G | |
01/31/2025 4:46 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Stueland Katherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2025 4:47 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2025 7:02 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025 8:04 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) Stueland Katherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025 8:06 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025 4:08 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) RUCH JOSHUA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2025 4:07 PM | Dechairo Bryan (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 11:55 AM | Dechairo Bryan (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/13/2025 7:36 AM | GeneDx Holdings Corp. (Filer) GeneDx Holdings Corp. (Filer) GeneDx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 4:53 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Stueland Katherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 4:54 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2025 4:02 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025 3:44 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) Stueland Katherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025 5:04 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 5:05 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Stueland Katherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2025 4:14 PM | GeneDx Holdings Corp. (Filer) GeneDx Holdings Corp. (Filer) GeneDx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/02/2025 3:31 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) Stueland Katherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024 5:21 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 5:22 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Stueland Katherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 7:40 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) Stueland Katherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024 7:41 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024 6:18 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2024 6:19 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Stueland Katherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 7:05 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) Stueland Katherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024 7:06 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024 6:21 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/02/2024 7:01 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024 5:21 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 7:21 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Ryan Jason (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 7:23 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) RUCH JOSHUA (Reporting)
| Form 4/A | |
11/21/2024 5:14 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2024 8:36 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) OPKO HEALTH, INC. (Filed by)
| Form SC 13D/A | |
11/19/2024 7:00 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Filed by)
| Form SC 13D/A | |
11/19/2024 7:00 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting) MOUNT SINAI HEALTH SYSTEM, INC. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2024 6:05 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Stueland Katherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
11/08/2024 10:06 AM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024 4:00 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Filed by)
| Form SC 13D/A | |
11/04/2024 4:01 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting) MOUNT SINAI HEALTH SYSTEM, INC. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2024 7:03 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024 4:14 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2024 4:13 PM | GeneDx Holdings Corp. (Issuer) GeneDx Holdings Corp. (Issuer) GeneDx (Issuer) Stueland Katherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 6:44 PM | GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject) Stueland Katherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024 6:45 PM | Feeley Kevin (Reporting) GeneDx Holdings Corp. (Subject) GeneDx Holdings Corp. (Subject) GeneDx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024 7:10 AM | GeneDx Holdings Corp. (Filer) GeneDx Holdings Corp. (Filer) GeneDx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |